Abstract. We report here the case of a 34-year-old female with puerperal alactogenesis. Her menstrual cycle was regular and breast development normal. She had delivered a healthy boy but could not breast-feed after parturition. Endocrinological studies disclosed that the cause was a prolactin (PRL) deficiency. In addition, she showed accompanying impaired ACTH secretion that was believed to be triggered by encephalitis, although her plasma levels of GH, TSH, LH and FSH remained intact. Pituitary MRI showed no specific findings and anti-pituitary antibody tests were negative. Interestingly, both her mother and grandmother also reported puerperal alactogenesis. The sequences of all five exons of the PRL gene, including promoter region and transcription initiation point, were surveyed in order to examine for certain genetic disorders, but no mutations were identified. Although it cannot be definitively concluded that this PRL deficiency was not a genomic DNA disorder, in our case at least, her PRL gene was normal and, therefore, was not directly responsible for the patient's impaired PRL secretion. This evidence suggests that familial puerperal alactogenesis and PRL deficiency can be induced by other causes such as via disorders of unknown transcription factors or molecules that contribute to translation of PRL gene.
PROLACTIN (PRL) is essential for lactogenesis, and its deficiency results in puerperal alactogenesis [1] . Several reasons, such as traumatic brain injury or a circulatory disorder, can induce PRL deficiency [2, 3] ; however, isolated PRL deficiency (IPD) is rare and only a few cases have been reported [4] [5] [6] [7] [8] . Of the pituitary hormones, PRL secretion is not easily obstructed, and therefore, a primary cause of IPD is unknown.
Zargar et al. previously reported a case of familial puerperal alactogenesis, and postulated it may be genetically transmitted IPD [5] . The patient showed normal breasts, normal pubertal development and a regular menstrual cycle. She had had two pregnancies and two live births, but failed to lactate after each delivery. To our knowledge, this report is the only previous report of familial history, with other reported cases being sporadic.
We encountered a PRL-deficient female with puerperal alactogenesis. She also suffered impaired adrenocorticotropic hormone (ACTH) secretion; however, the time of onset and the cause of the impaired secretion of the pituitary hormones were thought to be different. While the impaired ACTH secretion was considered due to encephalitis suffered a few years previous, the cause of the PRL deficiency was unclear, and its onset was conjectured, at least, to be before delivery. Interestingly, both her mother and grandmother had shown lactation failure, potentially indicating a genetic contribution except PRL gene to the disorder.
Case Report
A 34-year-old female was admitted to another hospital because of loss of consciousness, high fever (39.0°C) and right hemiparesis. On admission to that hospital, her blood pressure was 110/70 mmHg recumbent, her pulse rate 72/min regular, and body temperature 38.8°C. Her pupil size was 3.0 mm, with no difference between her right and left eye, and light reflex was prompt. Neck stiffness was detected. Her thyroid gland was not palpable. Peripheral lymph node swelling was not detectable. Neither hepatomegaly nor splenomegaly could be felt. There was no peripheral edema present. Conjugate deviation was detected in right side, and when her right arm was extended. Brain computerized tomography showed a low-density lesion in her left temporal lobe. Cerebrospinal fluid (CSF) tests showed high initial pressure (350 mmH 2 O), a low level of glucose (35 mg/dl) and a slight elevation in cell counts (7/mm 2 ). Hematological and coagulation tests revealed leukocytosis (14,600/µl) and a high concentration of fibrinogen (647 mg/dl). Blood chemistries were as follows; asparate aminotransferase 47 IU/ml, alanine aminotransferase 25 IU/ml, lactate dehydrogenase 291 IU/ml, choline esterase 8800 IU/ml, alkaline phosphatase 239 IU/ml, total bilirubin 1.8 mg/ml, creatinine kinase 940 IU/ml, total protein 7.5 g/dl, creatinine 0.9 mg/dl, blood urea nitrogen 15 mg/dl, Na 139 mEq/l, K 3.2 mEq/l, Cl 109 mEq/l, plasma glucose 169 mg/dl, c-reactive protein 13.2 mg/dl. Bacterial infection could not be ruled out because of the leukocytosis in the peripheral blood and low glucose level in the CSF. However, the cell count and normal protein concentration (34 mg/dl) are inappropriate for bacterial infection whereas encephalitis caused disturbance of consciousness and hemiparesis. There might be participation of bacterial infection; however, encephalitis induced by viral infection was strongly suspected. She was treated with both anti-viral and anti-bacterial drugs. Her general condition gradually recovered and she was discharged after 36 days in hospital.
She regularly visited an outpatient clinic for rehabilitation of a slight speech and swallowing disturbance. Forty days after discharge, she occasionally vomited and exhibited pre-tibial pitting edema. She was then again hospitalized because of loss of appetite and remarkable malaise. Her blood pressure was 100/60 mmHg recumbent, pulse rate 52/min regular, body temperature 34.0°C. Plasma glucose level was 20 mg/ dl, for which glucose solution was therefore administered. An endocrinological evaluation was carried out and simultaneously revealed low plasma levels of ACTH (5.9 pg/ml) and cortisol (0.5 µg/dl). Hence, adrenal deficiency was considered as the cause of her hypoglycemia, and treatment with methylprednisolone (125 mg/day) was commenced. Three days after initiation of treatment, her symptoms disappeared. After that, the medication was exchanged to prednisolone (20 mg/day). Twenty days after first treatment with steroid, she was transferred to our hospital for further endocrinological examination.
On admission, there were no significant aberrant findings relating to vital signs or upon a full physiological examination. There was no significant abnormality detected except for normocytic normochromic anemia (Hb 11.6 g/dl, Ht 35.3%) and hypercholesterolemia (255 mg/dl) in her blood tests and urinalysis. Plasma glucose was within the normal range (74 mg/ dl). Basal endocrinological data were as follows; GH 5.77 ng/ml, ACTH 1.3 pg/ml, LH 1.3 mIU/ml, FSH 5.7 mIU/ml, PRL 0.5 ng/ml, TSH 4.30 µIU/ml, ADH 1.6 pg/ml, IGF-1 210 ng/ml, cortisol 1.0 µg/dl, 17-KS 2.0 mg/day, 17-OHCS 0.9 mg/day, DHEA-S 20>ng/ ml, free T3 2.54 pg/ml, free T4 1.71 ng/ml. Pituitary magnetic resonance imaging (MRI) showed no significant findings (data not shown). Although, theoretically, treatment with steroid hormone should be stopped to precisely investigate endocrinological function, we felt to do so was unethical and so her medication was not cancelled but instead changed to dexamethasone (0.5 mg/day). The tests mentioned below were performed at 6 days after exchange of medicine. As shown in Table 1a , plasma levels of growth hormone, thyroid-stimulating hormone, luteinizing hormone and follicle-stimulating hormone were normal. Basal and corticotrophin-releasing hormone (CRH)-stimulated ACTH and cortisol levels were not detectable. Continuous CRH tests were performed to further investigate ACTH secretion and these also revealed undetectable levels of ACTH and cortisol (Table 1b) . These tests were performed during steroid treatment; therefore, the precise diagnosis as ACTH deficiency could not be made. However, low ACTH and cortisol levels in previous hospital indicated impaired ACTH secretion, hence, ACTH secretion in the present case was thought to be somewhat obstructed. In addition, her plasma basal and thyrotrophin-releasing hormone (TRH)-stimulated PRL levels were undetectable. Her men-strual cycle had previously been regular and the development of her breasts was normal. She had delivered a healthy boy but could not breast-feed after parturition. Both her mother and grandmother were also unable to breast-feed. Their PRL levels were not evaluated since we could not obtain their consent. They had only brothers, therefore, puerperal alactogenesis could not be evaluated.
In order to examine for a genetic disorder of the PRL gene, genomic DNA was obtained from the patient after she gave her informed consent. This study was approved by the local ethics committee of the Jikei University School of Medicine. Genomic DNA was isolated from peripheral blood leukocytes and directly analyzed via polymerase chain reaction using specific primers we designed ( Table 2) . For this purpose, 150 ng of genomic DNA was added to a 20-µl reaction mixture of 50 mM KCl, 20 mM Tris-HCl (pH 8.4), 2.0 mM MgCl 2 , 0.2 mM of each deoxynucleotide triphosphate, 0.5 µM of each primer, and 2 U Taq DNA polymerase. The PCR mixture was denatured for 5 min at 98°C and cycled for 30 times (96°C, 1 min; 45°C, 1 min; and 72°C, 1 min) followed by a 7-min extension at 72°C. The resulting PCR products were purified with a commercial column QIA Quick PCR purification kit (QIAGEN, Valencia, CA). Each purified product was used as a template for direct sequencing of the whole fragment. Sequencing was performed by the dideoxy method using Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA). Although the sequences of all five exons of the PRL gene were surveyed, there was no mutation identified. Based on these evidences, a diagnosis of complete PRL deficiency and impaired ACTH secretion were made. After evaluation of her endocrinological functions, her medication for steroid replacement was changed from dexamethasone to hydrocortisone (20 mg/day). Two year after discharge from our hospital, her dose of hydrocortisone was changed to 10 mg and she visits a hospital for treatment with steroid replacement every two months.
Discussion
The case we report here showed impaired secretion of two major pituitary hormones; namely ACTH and PRL. Several reports have previously indicated that such combined pituitary hormone deficiency (CPHD) can be induced by lymphocytic hypophysitis [9] or through mutation of transcriptional factors such as Prop-1 or Pit-1 [10] [11] [12] . However, the patterns of ACTH and PRL deficiencies are very rare, and a report about such CPHD induced by lymphocytic hypophysitis or disorders of transcriptional factors is not unprecedented. Puig et al. previously reported a female patient who showed PRL and ACTH deficiency and suggested an autoimmune etiology [13] . In the present case, simultaneous onset of impaired ACTH and PRL secretion could not be ruled out. However her alactogenesis was present before the encephalitis, and her family history and the unique pattern of the hormone deficiency suggested another cause.
Previous reports have shown that only small 
This test was performed after treatment with CRH (0.1 mg) for 5 days. [8] . Whilst the underlying cause of the disease is unclear, the results may indicate PRL deficiency can result following various conditions. PRL-null mice made by homologous recombination show normal growth and develop a normal ductal tree [14] . However, the ducts fail to develop lobular decorations with the result that null-mice are completely infertile.
Kauppila et al. reported a case of isolated PRL deficiency with puerperal alactogenesis after delivery [4] .
Although it was diagnosed as isolated PRL deficiency at the time of first pregnancy, she could become pregnant again. These opposing reports on mice and humans suggest that PRL may not always be necessary for pregnancy but that abnormality of the PRL gene may cause infertility. These findings are compatible with our case that showed no mutation of PRL gene and normal pregnancy. Although it cannot be definitively concluded that the PRL deficiency seen was not genetically-based, at least in our case the PRL gene was not primarily responsible for the impaired secretion of PRL. This evidence may indicate that familial puerperal alactogenesis and PRL deficiency may be induced by some alternate mechanisms, such as autoimmune or inflammatory disease.
